AdAlta

1AD · ASX

Public Market Listing

1ADASX

ASX primary exchange listing

Live quotes, historical charts, and market capitalization for AdAlta are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Phase 1
CXCR4Antibody-derived scaffold
Chronic Kidney Disease

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (5 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$0.4M—$0.9M$2.9Mreport ↗
View 4 more years
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$1.1M—$2.1M$3.5Mreport ↗
2023-FY$2.3M—$3.2M$3.3Mreport ↗
2022-FY$2.0M—$6.0M$4.4Mreport ↗
2021-FY$3.0M—$4.3M$4.2Mreport ↗